Literature DB >> 8080682

Colour Doppler demonstrates venous flow abnormalities in breast cancer patients with chronic arm swelling.

W E Svensson1, P S Mortimer, E Tohno, D O Cosgrove.   

Abstract

Chronic arm oedema following breast cancer treatment is traditionally attributed to lymphatic obstruction, with venous obstruction as an infrequent complicating factor. The axillo-subclavian venous systems of 81 patients with arm swelling following breast cancer treatment were examined with colour Doppler, duplex Doppler and grey scale ultrasound. Over half (57%) had evidence of venous outflow obstruction and a further 14% had signs of venous "congestion". Only 30% of the swollen arms had normal venous outflow. The venous systems of the contralateral non-swollen arms were all normal as were both arms in 28 control patients who had similar treatment but had not developed arm swelling. These findings suggest that venous outflow obstruction is an important contributory factor in the pathophysiology of arm swelling following breast cancer treatment.

Entities:  

Mesh:

Year:  1994        PMID: 8080682     DOI: 10.1016/0959-8049(94)90539-8

Source DB:  PubMed          Journal:  Eur J Cancer        ISSN: 0959-8049            Impact factor:   9.162


  4 in total

1.  Segmental blood flow and hemodynamic state of lymphedematous and nonlymphedematous arms.

Authors:  Leslie D Montgomery; Mary S Dietrich; Jane M Armer; B R Stewart; Sheila H Ridner
Journal:  Lymphat Res Biol       Date:  2011-03       Impact factor: 2.589

2.  Lymphoedema: Pathophysiology and management in resource-poor settings - relevance for lymphatic filariasis control programmes.

Authors:  Babar Vaqas; Terence J Ryan
Journal:  Filaria J       Date:  2003-03-12

3.  The axillary vein and its tributaries are not in the mirror image of the axillary artery and its branches.

Authors:  HyeYeon Lee; JongHo Bang; SooJung Kim; HeeJun Yang
Journal:  PLoS One       Date:  2019-01-10       Impact factor: 3.240

Review 4.  The Concept of Chronic Edema-A Neglected Public Health Issue and an International Response: The LIMPRINT Study.

Authors:  Christine Moffatt; Vaughan Keeley; Isabelle Quere
Journal:  Lymphat Res Biol       Date:  2019-04       Impact factor: 2.589

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.